Patent details
EP3638373
Title:
DOSAGE REGIMES FOR THE ADMINISTRATION OF AN ANTI-CD19 ADC
Basic Information
- Publication number:
- EP3638373
- PCT Application Number:
- EP2018065873
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP187320411
- PCT Publication Number:
- WO2018229222
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- DOSAGE REGIMES FOR THE ADMINISTRATION OF AN ANTI-CD19 ADC
- French Title of Invention:
- RÉGIMES POSOLOGIQUES POUR L'ADMINISTRATION D'UN CAM ANTI-CD19
- German Title of Invention:
- DOSIERUNGSSCHEMATA ZUR VERABREICHUNG EINES ANTI-CD19-ADC
- SPC Number:
-
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 30/09/2024
- Link to UPP Register:
-
European Patent Register
- Unitary Effect Request Withdrawal Date:
-
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 24/10/2024
- Unitary Effect Rejection Decision Date:
-
- Unitary Effect Date:
- 04/09/2024
- Unitary Effect Registration Date:
- 24/10/2024
- Unitary Effect Re-establishment of rights Filing Date:
-
- Unitary Effect Re-establishment of rights EPO Decision :
-
- Unitary Effect Re-establishment of rights EPO Decision Date:
-
- Explanatory Text UE:
-
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
-
Dates
- Filing date:
- 14/06/2018
- Grant date:
- 04/09/2024
- EP Publication Date:
- 22/04/2020
- PCT Publication Date:
- 20/12/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 04/09/2024
- EP B1 Publication Date:
- 04/09/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 14/06/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 28/08/2024
-
-
- Name:
- ADC Therapeutics SA
- Address:
- Route de la Corniche 3B, 1066 Epalinges, Switzerland (CH)
- Name:
- Medimmune Limited
- Address:
- Milstein Building
Granta Park, Cambridge, Cambridgeshire CB21 6GH, United Kingdom (GB)
Inventor
1
- Name:
- FEINGOLD, Jay Marshall
- Address:
- United States (US)
2
- Name:
- UNGAR, David Rodney
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201709444
- Priority Date:
- 14/06/2017
- Priority Country:
- United Kingdom (GB)
2
- Priority Number:
- 201709440
- Priority Date:
- 14/06/2017
- Priority Country:
- United Kingdom (GB)
3
- Priority Number:
- 201710494
- Priority Date:
- 30/06/2017
- Priority Country:
- United Kingdom (GB)
4
- Priority Number:
- 201710495
- Priority Date:
- 30/06/2017
- Priority Country:
- United Kingdom (GB)
5
- Priority Number:
- 201720543
- Priority Date:
- 08/12/2017
- Priority Country:
- United Kingdom (GB)
6
- Priority Number:
- 201720542
- Priority Date:
- 08/12/2017
- Priority Country:
- United Kingdom (GB)
7
- Priority Number:
- 201802679
- Priority Date:
- 20/02/2018
- Priority Country:
- United Kingdom (GB)
8
- Priority Number:
- 201808473
- Priority Date:
- 23/05/2018
- Priority Country:
- United Kingdom (GB)
Classification
- IPC classification:
-
A61P 39/00;
A61K 31/5517;
C07K 16/28;
A61K 47/68;
A61P 35/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202436
- Publication date:
- 04/09/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202445
- Publication date:
- 06/11/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202448
- Publication date:
- 27/11/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
Filing date |
Document type |
Number of pages |